We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

registration required

or
for more website access

This content can only be viewed by subscribers and registered users of Investors Chronicle.

Subscribe or register free today

Phytopharm's bleak future

What's new...?

■ Failure of Cogane in Parkinson's treatment

■ Management waits on strategic review

■ Running as a cash shell

registration required

visible-status-Standard story-url-Phytopharm broker tip 200213.xml

By Julian Hofmann,
21 February 2013

Print this article
Comments

Related Companies

Register today and get...

Register today and get...
Please note terms & conditions apply